Skip to main content

Labcorp income statement

  • LH · NYSE
  • Healthcare
  • Health Care Services
  • S&P 500
$370.48−0.49%Close 13 Nov 2026 · Market value $30.04B

Labcorp reported revenue of $14.0 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 7.2% from fiscal 2024. Net income was $877 million and diluted earnings per share $10.46.

From Labcorp's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Labcorp income statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$4.07B$4.51B$4.69B$5.00B$5.54B$5.67B$5.81B$6.01B$8.68B$9.55B$10.31B$11.33B$11.55B$13.98B$13.14B$11.86B$12.16B$13.01B$13.95B$14.59B
Revenue growth—+10.7%+4.2%+6.6%+10.8%+2.3%+2.4%+3.5%+44.4%+10.1%+7.9%+9.9%+2.0%+21.0%−6.0%−9.7%+2.5%+7.0%+7.2%—
Cost of revenue$2.38B$2.63B$2.72B$2.91B$3.27B$3.42B$3.59B$3.81B$5.78B$6.70B$7.22B$8.16B$8.30B$9.03B$8.14B$8.15B$8.80B$9.38B$9.94B$10.37B
Gross profit$1.69B$1.87B$1.97B$2.10B$2.27B$2.25B$2.22B$2.20B$2.90B$2.85B$3.09B$3.18B$3.25B$4.95B$4.99B$3.71B$3.36B$3.62B$4.01B$4.23B
Gross margin41.6%41.6%42.0%41.9%41.0%39.7%38.3%36.6%33.4%29.9%30.0%28.0%28.1%35.4%38.0%31.3%27.7%27.9%28.8%29.0%
Selling, general and administrative$808.7M$935.1M$958.9M$1.03B$1.16B$1.11B$1.13B$1.20B$1.63B$1.35B$1.50B$1.57B$1.62B$1.73B$1.69B$1.76B$2.02B$2.23B$2.22B$2.28B
Operating income$777.0M$842.9M$935.9M$978.8M$948.4M$1.02B$990.9M$910.4M$996.8M$1.27B$1.31B$1.33B$1.33B$2.45B$3.05B$1.44B$725.6M$1.09B$1.38B$1.50B
Operating margin19.1%18.7%19.9%19.6%17.1%18.0%17.1%15.1%11.5%13.3%12.7%11.7%11.5%17.5%23.2%12.1%6.0%8.4%9.9%10.3%
Interest expense$56.60M$72.00M$62.90M$70.00M$87.50M$94.50M$96.50M$109.5M$274.9M$219.1M$235.1M$244.2M$240.7M$207.4M$211.8M$179.8M$199.6M$208.3M$224.1M$230.3M
Other income and expense————−$82.30M−$79.30M−$75.30M−$83.70M−$270.8M−$197.0M−$227.7M−$57.40M−$225.3M−$226.3M——————
Income tax expense$325.5M$307.9M$329.0M$344.0M$333.0M$359.4M$340.2M$314.1M$287.3M$360.7M−$155.4M$384.4M$280.0M$662.1M$690.0M$233.9M$188.5M$212.4M$229.8M$219.6M
Net income$476.8M$464.5M$543.3M$558.2M$519.7M$583.1M$573.8M$511.2M$437.6M$711.8M$1.23B$883.7M$823.8M$1.56B$2.38B$1.28B$418.0M$746.0M$876.5M$1.00B
Net margin11.7%10.3%11.6%11.2%9.4%10.3%9.9%8.5%5.0%7.5%11.9%7.8%7.1%11.1%18.1%10.8%3.4%5.7%6.3%6.9%
Net income to common shareholders——$543.3M$558.2M$519.7M$583.1M$573.8M$511.2M$437.6M$711.8M$1.23B$883.7M$823.8M$1.56B$2.38B$1.28B$418.0M$746.0M$876.5M—
EPS · diluted$3.93$4.16$4.98$5.29$5.11$5.99$6.25$5.91$4.35$6.82$11.81$8.61$8.35$15.88$24.39$13.97$4.77$8.84$10.46$12.17
Diluted weighted average shares121M112M109M105M102M97.4M91.8M86.4M101M104M104M103M98.6M98.0M97.5M91.6M87.6M84.4M83.8M82.5M
Basic weighted average shares——107M103M100M95.7M90.2M84.8M98.8M103M102M101M97.9M97.3M96.7M91.1M87.1M83.9M83.2M81.9M
EBITDA$939.8M$1.02B$1.13B$1.18B$1.18B$1.25B$1.22B$1.16B$1.45B$1.77B$1.84B$1.88B$1.91B$3.07B$3.63B$1.97B$1.30B$1.73B$2.07B$2.21B
EBITDA margin23.1%22.7%24.1%23.6%21.3%22.1%21.0%19.2%16.8%18.5%17.8%16.6%16.5%22.0%27.6%16.6%10.7%13.3%14.8%15.1%
Depreciation & amortization$162.8M$179.7M$195.1M$203.6M$231.4M$229.8M$230.1M$245.5M$457.8M$499.2M$533.2M$552.1M$577.2M$624.7M$577.0M$537.2M$577.3M$643.5M$681.1M$708.3M
Stock-based compensation$35.40M$36.20M$36.40M$40.00M$48.90M$40.70M$37.30M$45.70M$102.1M$109.6M$109.7M$91.60M$107.0M$111.7M$132.9M$116.8M$128.7M$116.7M$125.8M$127.1M
Dividends per share———————————————$2.16$2.88$2.88$2.88$2.88

Quarterly

Labcorp income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$3.03B$3.18B$3.22B$3.28B$3.33B$3.35B$3.53B$3.56B$3.52B$3.54B$3.73B$3.81B
Cost of revenue$2.21B$2.28B$2.29B$2.38B$2.43B$2.40B$2.48B$2.54B$2.52B$2.52B$2.62B$2.70B
Gross profit$821.4M$897.3M$926.4M$904.4M$896.3M$948.0M$1.05B$1.03B$993.2M$1.01B$1.11B$1.11B
Gross margin27.1%28.2%28.8%27.6%26.9%28.3%29.7%28.8%28.2%28.7%29.8%29.1%
Selling, general and administrative$532.9M$508.4M$557.8M$568.6M$595.2M$546.0M$579.3M$553.1M$537.9M$551.0M$577.2M$611.4M
Operating income−$122.8M$321.3M$294.8M$254.1M$216.5M$326.0M$394.5M$396.6M$267.6M$380.8M$451.6M$402.1M
Operating margin−4.0%10.1%9.2%7.7%6.5%9.7%11.2%11.1%7.6%10.8%12.1%10.6%
Interest expense$48.80M$46.90M$47.60M$50.40M$63.40M$56.00M$57.10M$56.00M$55.00M$55.10M$61.10M$59.10M
Income tax expense$19.70M$69.10M$62.10M$41.00M$40.20M$62.20M$66.40M$75.50M$25.70M$41.70M$87.30M$64.90M
Net income−$167.1M$228.0M$205.3M$169.3M$143.4M$212.8M$237.9M$261.1M$164.7M$277.8M$298.7M$262.8M
Net margin−5.5%7.2%6.4%5.2%4.3%6.4%6.7%7.3%4.7%7.9%8.0%6.9%
Net income to common shareholders−$128.3M$228.0M$205.3M$169.3M$143.4M$212.8M$237.9M$261.1M$164.7M———
EPS · diluted−$1.50$2.69$2.43$2.00$1.71$2.52$2.84$3.12$1.98$3.35$3.64$3.22
Diluted weighted average shares85.5M84.7M84.3M84.4M84.1M84.3M83.9M83.7M83.4M82.9M82.0M81.6M
Basic weighted average shares84.7M84.1M84.1M84.0M83.6M83.6M83.4M83.1M82.6M82.3M81.7M81.1M
EBITDA$23.60M$475.8M$451.7M$415.6M$387.1M$492.8M$564.8M$567.6M$440.6M$554.1M$630.6M$585.1M
EBITDA margin0.8%15.0%14.0%12.7%11.6%14.7%16.0%15.9%12.5%15.7%16.9%15.4%
Depreciation & amortization$146.4M$154.5M$156.9M$161.5M$170.6M$166.8M$170.3M$171.0M$173.0M$173.3M$179.0M$183.0M
Stock-based compensation$27.00M$31.60M$30.80M$27.00M$27.30M$32.80M$34.10M$29.20M$29.70M$31.70M$34.90M$30.80M
Dividends per share——$0.72$0.72$0.72$0.72$0.72$0.72$0.72$0.72$0.72$0.72

The main figures as JSON and plain text. See data and methodology.

LH in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.